| Literature DB >> 36159807 |
Zhichu Chen1,2, Dong Huang1, Prakaiwan Yongyut3, Guangbin Li4, María Ángeles Esteban2, Orapint Jintasataporn3, Junming Deng4, Wenbing Zhang1, Qinghui Ai1, Kangsen Mai1, Yanjiao Zhang1.
Abstract
Vitamin D3 (VD3) participated widely in the nuclear factor-κB (NF-κB)-mediated inflammation, apoptosis, and autophagy through the vitamin D receptor (VDR). However, the molecular mechanisms remain not understood in teleost. The present study investigated the functions of VD3/VDR on intestinal inflammation, autophagy, and apoptosis of turbot in vivo and in vitro. Triple replicates of 30 fish were fed with each of three diets with graded levels of 32.0 (D0), 1012.6 (D1), and 3978.2 (D2) IU/kg VD3. Obvious intestinal enteritis was observed in the D0 group and followed with dysfunction of intestinal mucosal barriers. The intestinal inflammatory response induced by VD3 deficiency was regulated by the NF-κB/inflammasome signalling. The promotion of intestinal apoptosis and suppression of intestinal autophagy were also observed in the D0 group. Similarly, VD3 deficiency in vitro induced more intense inflammation regulated by NF-κB/inflammasome signalling. The mutually exclusive apoptosis and autophagy were also observed in the group without 1,25(OH)2D3 in vitro, accompanied by similar changes in apoptosis and autophagy increased apoptosis. The gene expression of VDRs was significantly increased with the increasing VD3 supplementation both in vivo and in vitro. Moreover, VDR knockdown in turbot resulted in intestinal inflammation, and this process relied on the activation of inflammasome mediated by NF-κB signalling. Simultaneously, intestinal apoptosis was promoted, whereas intestinal autophagy was inhibited. In conclusion, VD3 deficiency could induce intestinal inflammation via activation of the NF-κB/inflammasome pathway, intestinal apoptosis, and autophagy formed a mutually exclusive relation in teleost. And VDR is the critical molecule in those processes.Entities:
Keywords: NF-κB; apoptosis; autophagy; inflammasome; inflammation; vitamin D3; vitamin D3 receptor
Mesh:
Substances:
Year: 2022 PMID: 36159807 PMCID: PMC9493454 DOI: 10.3389/fimmu.2022.986593
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 8.786
Formulation and proximate composition of the experimental diets (% dry matter).
| Ingredients | Diets | ||
|---|---|---|---|
| D0 | D1 | D2 | |
| Casein (vitamin free) | 37.20 | 37.20 | 37.20 |
| Gelatin | 9.30 | 9.30 | 9.30 |
| Crystalline amino acid | 5.60 | 5.60 | 5.60 |
| Fish oil | 5.50 | 5.50 | 5.50 |
| Soya oil | 4.10 | 4.10 | 4.10 |
| Soybean lecithin | 1.00 | 1.00 | 1.00 |
| Choline chloride | 0.30 | 0.30 | 0.30 |
| Ca(H2PO4)2·H2O | 1.50 | 1.50 | 1.50 |
| Ethoxyquin | 0.05 | 0.05 | 0.05 |
| Y2O3 | 0.10 | 0.10 | 0.10 |
| Calcium propionate | 0.10 | 0.10 | 0.10 |
| Phagostimulant | 1.00 | 1.00 | 1.00 |
| Dextrin | 26.50 | 26.50 | 26.50 |
| Microcrystalline cellulose | 5.75 | 5.75 | 5.75 |
| Mineral premix | 1.00 | 1.00 | 1.00 |
| Vitamin premix | 1.00 | 1.00 | 1.00 |
| Vitamin D3 (add value, IU/kg) | 0.00 | 1,000.00 | 4,000.00 |
|
| |||
| Vitamin D3 (measured value, IU/kg) | 32.00 | 1,012.60 | 3,978.20 |
| Moisture | 9.83 | 9.21 | 10.09 |
| Crude protein | 50.29 | 50.14 | 50.11 |
| Crude lipid | 9.39 | 9.59 | 9.65 |
| Ash | 3.44 | 3.40 | 3.42 |
Crystalline amino acid premix (g/100 g diet): arginine, 1.69; histidine, 0.55; isoleucine, 0.22; leucine, 0.14; lysine, 0.73; phenylalanine, 0.50; threonine, 0.61; valine, 0.13; alanine, 1.32; aspartic acid, 1.63; glycine, 1.62; serine, 0.42; cystine, 0.40; tyrosine, 0.10.
Phagostimulant (g/kg diet): betaine, 4; DMPT, 2; threonine, 2; glycine, 1; inosine-5′-diphosphate trisodium salt, 1.
Mineral premix (mg/kg diet): FeSO4·H2O, 80; ZnSO4·H2O, 50; CuSO4·5H2O, 10; MnSO4·H2O, 45; KI, 60; CoCl2·6H2O (1%), 50; Na2SeO3 (1%), 20; MgSO4·7H2O, 1200; zeolite, 8485.
Vitamin premix (mg/kg diet): retinyl acetate, 32; DL-α-tocopherol acetate, 240; vitamin K3, 10; thiamin, 25; riboflavin (80%), 45; pyridoxine hydrochloride, 20; vitamin B12 (1%), 10; Lascorbyl-2-monophosphate-Na (35%), 2000; calcium pantothenate, 60; nicotinic acid, 200; inositol, 800; biotin (2%), 60; folic acid, 20; cellulose, 6478.
siRNA sequences.
| Sequence | |
|---|---|
| VDRA siRNA 1 | CAATGTTTCTAGATGTTTA |
| VDRA siRNA 2 | GTTCAAGATTGTAAATCAA |
| VDRA siRNA 3 | GCTGTGGTGTAGCAAGTTA |
| VDRB siRNA 1 | GGACCTTCATATAATACAA |
| VDRB siRNA 2 | GGTTGATGTATTTGACTAA |
| VDRB siRNA 3 | GGATGTACACCATACTCTA |
| NC siRNA | GCTGACCCTGAAGTTCATC |
Primers used in quantitative real-time PCR (qRT-PCR).
| Target gene | Forward primer (5′-3′) | Reverse primer (5′-3′) | GenBank no. |
|---|---|---|---|
|
| ATGTGGAGTGTGTCGGCTT | AGACCTTGCACTGCATCTG | MF370857.1 |
|
| TTGTCCCTGACCAAGTGATG | ACAAAGCCTGTCCAAGATCG | JU370277.1 |
|
| ATGTGGAGTGTGTCGGCTT | AGACCTTGCACTGCATCTG | MF370857.1 |
|
| GCCTACATCCACAAAGACAACG | TCATTCCCAGCACTAATACAATCAC | KU238183.1 |
|
| CCAAGATGGACACCGGAACT | CCTCCGGTGTTTAGGTCACG | MT787206.1 |
|
| GAGTTTTCAGCTTCCGTGTT | AGAGAACCTGTCACTGATAGATGC | KU238184.1 |
|
| CCACTTCAATGCCATGACC | TACTGCGCCTAAAGAACCCT | XM_035644868.1 |
|
| TAATGGCAGTTGCACCATCACC | TCCTCTGCACTTCCTCGTCT | XM_035630011.1 |
|
| ATGGTGCGATTTCTGTTC | CACTTTGGGTCGTCTTTG | AJ295836.2 |
|
| GGACAGGGCTGGTACAACAC | TTCAATTAGTGCCACGACAAAGAG | AJ276709.1 |
|
| GGAATTAATCCCTGGCAACTCT | ACCTCTTTGCCTGAGTGT | XM_035638412.1 |
|
| GCTTTCCCGATCATCTTCTG | GGTTTCCCAGATTCCCATTC | DQ400686.1 |
|
| CTGCAGGACTGGCTCAAAGG | CATGGTCAGGATGTATGGTGGT | KU238187.1 |
|
| TCGACGAGCTCAAGTCCGAT | CTGATCCAGCTCGCCCAT | XM_035632547.1 |
|
| TCGTTCGTCTGTGTCCTGTTGAG | GCTGTGGAGAAGGCGTAGAGG | XM_035637276.1 |
|
| GTGAACTGGGGCCGGATTATC | CCATCCCCCGTTGTCCATAAT | XM_035631516.1 |
|
| GCTCCAGAGGATGATAAATAAC | AAAGTAGAAGAGTGCGACCA | XM_020094597.1 |
|
| GCACCCCAACAAGATCCCT | GATCTTGACCAGCTCGCTCA | XM_035642079.1 |
|
| GCAGATCACATTCTCCGCTCT | TGCCATCCAGCGAGACACC | XM_035621910.1 |
|
| CAGTGTATGAAGCCAGCAGAG | GGTCGTATTTGTCCTCATTAACTC | AY008305.1 |
|
| AACACAGGAAGCAGCAGAAC | ACGGCAGTGATGGTCTCTC | DQ848899.1 |
Figure 1Inflammation, apoptosis, and autophagy of intestine with VD3 treatments in vivo. (A) H&E staining of intestine (Black bars, 200 μm or 50 μm), Black arrows indicate widening of the intestinal lamina propria. (B) Alkaline phosphatase, acid phosphatase activities, and lysozyme activities. (C) The relative mRNA expression level of MUC2, MUC18, CLDN4, TRIC, JAM1, and ZO1. (D) The relative mRNA expression level of VDRA&B. (E) The mRNA expression levels of IL1B, TNF, IL8, IFNG, TGFB1, and IL10. (F) The mRNA expression levels of CASP3, BCL2, BAX, MAP1LC3B, and ATG16L1. (G, H) DNA fragmentation and quantification of the density of the 180 to 200 bp DNA band. (I-K) The level of ASC, intranuclear NF-κB p65, total IκB and phosphorylated IκB, CASP3, BCL2, MAP1LC3B, and ATG16L1 were analyzed and quantitated by western blot. The blots of ASC, IκBα, p-IκBα ser32 ser36, CASP3, BCL2, MAP1LC3B, and ATG16L1 were used for GAPDH loading control, while the blot of NF-κB p65 was used for Lamin B loading control. Error bars of columns denote SD (n = 3), and columns with different letters above them are significantly different (P < 0.05).
Figure 2Inflammation, apoptosis, and autophagy of intestinal epithelial cells with VD3 treatments in vitro. (A) The relative mRNA expression level of CLDN4, TRIC, JAM1, and ZO1. (B) The relative mRNA expression level of VDRA&B. (C) The mRNA expression levels of IL1B, TNF, IL8, IFNG, TGFB1, and IL10. (D) The mRNA expression levels of CASP3, BCL2, BAX, MAP1LC3B, and ATG16L1. (E) Confocal images of TUNEL assay (White bars, 50 μm). (F) Confocal images of MAP1LC3B fluorescence (White bars, 50 μm). (G-I) The level of ASC, intranuclear NF-κB p65, total IκB and phosphorylated IκB, CASP3, BCL2, MAP1LC3B, and ATG16L1 were analyzed and quantitated by western blot. The blots of ASC, IκBα, p-IκBα ser32 ser36, CASP3, BCL2, MAP1LC3B, and ATG16L1 were used for GAPDH loading control, while the blot of NF-κB p65 was used for Lamin B loading control. Error bars of columns denote SD (n = 3), and columns with different letters above them are significantly different (P < 0.05).
Figure 3VDR knockdown in vivo on inflammation, apoptosis, and autophagy in the intestine. (A) The relative mRNA expression level of VDRA&B in the intestine treated with VDRA&B siRNAs. (B) The mRNA expression levels of IL1B, IL8, TGFB1, and IL10. (C) The mRNA expression levels of CASP3, BCL2, BAX, MAP1LC3B, and ATG16L1. (D-F) The level of ASC, intranuclear NF-κB p65, total IκB and phosphorylated IκB, CASP3, BCL2, MAP1LC3B, and ATG16L1 were analyzed and quantitated by western blot. The blots of ASC, IκBα, p-IκBα ser32 ser36, CASP3, BCL2, MAP1LC3B, and ATG16L1 were used for GAPDH loading control, while the blot of NF-κB p65 was used for Lamin B loading control. Error bars of columns denote SD (n = 3), and columns with different letters above them are significantly different (P < 0.05).